• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CVS Health, UCLA Health Partner to Bolster Hospital Capacity for COVID-19

by Jasmine Pennic 04/17/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
CVS Health, UCLA Health Partner to Bolster Hospital Capacity for COVID-19

What You Should Know:

– CVS Health announced it is working with hospitals and providers, including major systems like UCLA Health, to support their solutions for creating much-needed hospital bed capacity during the pandemic.

– Hospitals around the country are expanding their capacity to meet the anticipated needs as a result of the COVID-19 pandemic.

– Current estimates project that hospitals nationwide need to increase capacity by more than 36,000 hospital beds.

– In addition, CMS recently issued temporary regulatory changes that enable faster patient discharge and home-based care to help bolster hospital capacity for COVID-19.

CVS Health, today announced it is working with hospitals and providers, including UCLA Health, to support solutions for creating much-needed hospital bed capacity during the pandemic. Coram, the company’s infusion care business has enhanced its existing home infusion capacity and capabilities to help transition eligible IV-therapy patients to home-based care. This includes enhanced clinical monitoring, virtual support and oversight through telehealth to complement existing personalized in-home support, coordination and administration of medications and supplies. In California, the state is working to add 50,000 hospital beds to make enough room for anticipated COVID-19 patients.

Why It Matters

Hospitals around the country are expanding their capacity to meet the anticipated needs as a result of the COVID-19 pandemic. Current estimates project that hospitals nationwide need to increase capacity by more than 36,000 hospital beds. In addition, CMS recently issued temporary regulatory changes that enable faster patient discharge and home-based care to help bolster hospital capacity for COVID-19.

Coram, the company’s infusion care business is:

Enabling care for patients with high acuity needs that may require additional clinical oversight, monitoring, and in-person care, by working with home health care agency partners as needed.  Working with insurers to help streamline access to this type of care during the pandemic by escalating the prior authorization process and other requirements that may inhibit same-day hospital discharge.

Collaboration Details with UCLA Health

Coram is working with UCLA Health to identify and begin transitioning stable patients to home-based nursing care. Patients with a range of conditions that may require infusion therapy, including hydration and nutritional support, anti-infectives and/or specialty medications for chronic condition management, will be considered. Once home, Coram’s specialized nurses will provide and coordinate a range of care, including daily visits and monitoring, medication administration, IV catheter line care, lab draws and educational support via telehealth. Coram is scaling this approach nationwide in other markets with high rates of COVID-19 cases and working with home health agencies to enable care for patients with high acuity needs that may require additional clinical oversight and monitoring.

“We’re able to create a clinically appropriate and safe in-home care setting, so hospitals can focus on treating those impacted by COVID-19,” said Sree Chaguturu, M.D., Chief Medical Officer of CVS Caremark and CVS Specialty. “Amid this unprecedented public health challenge, home can be the safest place for patients recovering from a range of illnesses and can also help minimize their risk of contracting COVID-19.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CMS, Coronavirus (COVID-19), CVS Health, Home Care, In-Home Care, medication, Partners, Prior Authorization, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |